You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 114 No. 1, January 1988 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ototoxicity of Vasocidin Drops Applied to the Chinchilla Middle Ear

Orval E. Brown, MD; Charles G. Wright, PhD; Masami Masaki, MD; William L. Meyerhoff, MD, PhD

Arch Otolaryngol Head Neck Surg. 1988;114(1):56-59.


Abstract

• Some widely used ototopical preparations are potentially toxic to the middle and inner ear. Vasocidin Ophthalmic Solution (sulfacetamide sodium and prednisolone sodium phosphate) has been advocated as an alternative agent that may have fewer toxic side effects in the treatment of otorrhea. Vasocidin was introduced into the bullae of nine chinchillas to investigate the effects on the middle and inner ear. The organ of Corti and stria vascularis were found to be entirely normal in 17 of the 18 temporal bones studied. Changes observed in the middle ears at one week included inflammation, hemorrhage, and effusion. Examination of specimens at four weeks revealed resolution of most of the inflammatory changes. The results of this experimental study indicate that Vasocidin causes reversible middle ear inflammation with little or no toxic effect on inner ear structures.

(Arch Otolaryngol Head Neck Surg 1988;114:56-59)



Author Affiliations

From the Department of Otorhinolaryngology, University of Texas Health Science Center, Dallas.


Footnotes

Accepted for publication July 18, 1987.

Read before the Fourth International Symposium on Recent Advances in Otitis Media, Bal Harbour, Fla, June 4, 1987.

Reprint requests to Department of Otorhinolaryngology, University of Texas Health Science Center, 5323 Harry Hines Blvd, Dallas, TX 75235 (Dr Brown).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Ototoxicity of Topical Ticarcillin and Clavulanic Acid in the Chinchilla
Jakob et al.
Arch Otolaryngol Head Neck Surg 1995;121:39-43.
ABSTRACT  

Ciprofloxacin: Use as a Topical Otic Preparation
Brownlee et al.
Arch Otolaryngol Head Neck Surg 1992;118:392-396.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.